Last reviewed · How we verify
Drug-Drug Interaction Study to Investigate the Effect of Ketoconazole on the Pharmacokinetic Properties of CKD-501 in Healthy Male Volunteer: Open, Randomised, 2-way Crossover, Clinical Trial
The purpose of this study is to assess the effect of Ketoconazole on the pharmacokinetic characteristics of CKD-501 in healthy subject.
Details
| Lead sponsor | Chong Kun Dang Pharmaceutical |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | 2011-03 |
| Completion | 2011-06 |
Conditions
- Type 2 Diabetes Mellitus
Interventions
- CKD-501, Ketoconazole
Primary outcomes
- CKD-501 AUC — 0(Day 5), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 24, 36, 48hr
Countries
South Korea